title: Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy.
abstract: Anomalous inflammatory responses triggered by the metabolic syndrome cause renal injury. This discovery links renal lipid accumulation with lipotoxicity to inflammation and may explain the insidious fibrosis and cellular decay characteristic of nephropathy in the metabolic syndrome. However, it is not clear whether control of inflammation protects the kidney independently of lipid accumulation, which is a required step for lipotoxicity in hyperglycemia and dyslipidemia. We hypothesized that in rats with the metabolic syndrome, and overt nephropathy, treatment with mycophenolate mofetil (MMF; 10 mg.kg(-1).day(-1) ip for 14 wk) would reduce the abnormal renal lipid depots and limit renal inflammation and injury. We studied groups of lean and obese F1 hybrid Zucker fatty diabetic/spontaneous hypertensive heart failure (ZS) rats. MMF did not affect lean rats. In obese ZS rats, MMF did not change severe hyperglycemia or the higher kidney loads of unutilized lipid and peroxidation products. Nonetheless, MMF dramatically reduced diabetes/obesity-derived systemic and renal inflammation, limited renal size, hyperfiltration, and fibrosis. These data indicate that in rats, anti-inflammatory therapy presumably acting downstream, and independently of lipotoxicity, can effectively limit renal injury and fibrosis.
authors.affiliation: Departments of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. jhdoming@iupui.edu
authors.forename: Jesus
authors.initials: J
authors.lastname: Dominguez
authors.forename: Pengfei
authors.initials: P
authors.lastname: Wu
authors.forename: C Subah
authors.initials: CS
authors.lastname: Packer
authors.forename: Constance
authors.initials: C
authors.lastname: Temm
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: Kelly
mesh_terms: D000375:Aging; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001786:Blood Glucose; D002784:Cholesterol / Q000097:blood; D007249:Inflammation / Q000378:metabolism*; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000235:genetics / Q000378:metabolism*; D008297:Male; D024821:Metabolic Syndrome / Q000235:genetics / Q000378:metabolism*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D009765:Obesity; D010641:Phenotype; D051381:Rats; D014280:Triglycerides / Q000097:blood
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001786:Blood Glucose; D014280:Triglycerides; D002784:Cholesterol; D009173:Mycophenolic Acid